Pacific Biosciences of California Inc
(NAS:PACB)
$
1.855
0.055 (3.06%)
Market Cap: 504.18 Mil
Enterprise Value: 905.70 Mil
PE Ratio: 0
PB Ratio: 1.02
GF Score: 62/100 Pacific Biosciences of California Inc at Bank of America Global Healthcare Conference Transcript
May 10, 2023 / 04:20PM GMT
Release Date Price:
$11.91
(-1.00%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research
I'm Derik De Bruin, the Senior Life Sciences and Diagnostics Tools analyst here at Bank of America, and welcome to our 2023 healthcare conference coming to you live from the Encore Hotel here in fabulous Las Vegas.
Our next presentation, our next discussion is with Pacific Biosciences with Christian Henry, Chief Executive Officer. Christian, welcome.
Christian O. Henry
Pacific Biosciences of California, Inc. - President, CEO & Director
Thank you. Appreciate the opportunity.
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research
You just reported Q1 results last week. Did you want to do some remarks? Or should we just jump right into the Q&A?
Christian O. Henry
Pacific Biosciences of California, Inc. - President, CEO & Director
Well, I think we can jump right in. We did have a great quarter and Revio, our new flagship sequencer is off to a fantastic start
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot